Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

Europe - EPA:ALBFR - FR0010202606 - Common Stock

229 EUR
+9 (+4.09%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

6

Overall ALBFR gets a fundamental rating of 6 out of 10. We evaluated ALBFR against 103 industry peers in the Software industry. Both the health and profitability get an excellent rating, making ALBFR a very profitable company, without any liquidiy or solvency issues. ALBFR shows excellent growth, but is valued quite expensive already. These ratings could make ALBFR a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ALBFR had positive earnings in the past year.
In the past year ALBFR had a positive cash flow from operations.
Each year in the past 5 years ALBFR has been profitable.
In the past 5 years ALBFR always reported a positive cash flow from operatings.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

ALBFR has a Return On Assets of 10.30%. This is amongst the best in the industry. ALBFR outperforms 84.47% of its industry peers.
With an excellent Return On Equity value of 20.04%, ALBFR belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
ALBFR's Return On Invested Capital of 8.78% is fine compared to the rest of the industry. ALBFR outperforms 67.96% of its industry peers.
ALBFR had an Average Return On Invested Capital over the past 3 years of 8.57%. This is below the industry average of 12.80%.
The last Return On Invested Capital (8.78%) for ALBFR is above the 3 year average (8.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROIC 8.78%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ALBFR's Profit Margin of 14.36% is fine compared to the rest of the industry. ALBFR outperforms 66.02% of its industry peers.
ALBFR's Profit Margin has improved in the last couple of years.
ALBFR has a Operating Margin (10.56%) which is comparable to the rest of the industry.
ALBFR's Operating Margin has improved in the last couple of years.
ALBFR has a Gross Margin (75.67%) which is in line with its industry peers.
ALBFR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

ALBFR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ALBFR has more shares outstanding than it did 1 year ago.
ALBFR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALBFR has an improved debt to assets ratio.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.46 indicates that ALBFR is not in any danger for bankruptcy at the moment.
ALBFR has a Altman-Z score of 7.46. This is amongst the best in the industry. ALBFR outperforms 80.58% of its industry peers.
The Debt to FCF ratio of ALBFR is 0.92, which is an excellent value as it means it would take ALBFR, only 0.92 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALBFR (0.92) is better than 80.58% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that ALBFR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, ALBFR is doing good in the industry, outperforming 64.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Altman-Z 7.46
ROIC/WACC1.1
WACC8%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.55 indicates that ALBFR should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.55, ALBFR is doing good in the industry, outperforming 63.11% of the companies in the same industry.
A Quick Ratio of 1.55 indicates that ALBFR should not have too much problems paying its short term obligations.
ALBFR has a Quick ratio of 1.55. This is in the better half of the industry: ALBFR outperforms 66.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.62%, which is quite impressive.
ALBFR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.85% yearly.
Looking at the last year, ALBFR shows a very strong growth in Revenue. The Revenue has grown by 25.69%.
The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%

3.2 Future

ALBFR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
ALBFR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.57% yearly.
EPS Next Y10.08%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.04 indicates a quite expensive valuation of ALBFR.
ALBFR's Price/Earnings ratio is a bit cheaper when compared to the industry. ALBFR is cheaper than 60.19% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALBFR to the average of the S&P500 Index (27.41), we can say ALBFR is valued expensively.
Based on the Price/Forward Earnings ratio of 38.77, the valuation of ALBFR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, ALBFR is valued quite expensively.
Industry RankSector Rank
PE 44.04
Fwd PE 38.77
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ALBFR's Enterprise Value to EBITDA is on the same level as the industry average.
63.11% of the companies in the same industry are more expensive than ALBFR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 40.1
EV/EBITDA 45.22
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALBFR does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ALBFR may justify a higher PE ratio.
PEG (NY)4.37
PEG (5Y)1.58
EPS Next 2Y11.31%
EPS Next 3Y11.26%

More info and screens

0

5. Dividend

5.1 Amount

ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIDETRADE

EPA:ALBFR (9/18/2025, 7:00:00 PM)

229

+9 (+4.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-15 2025-04-15
Earnings (Next)09-17 2025-09-17
Inst Owners18.26%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap343.50M
Analysts84
Price Target290.7 (26.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.43%
EPS NY rev (3m)-0.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE 44.04
Fwd PE 38.77
P/S 6.25
P/FCF 40.1
P/OCF 35.9
P/B 8.72
P/tB 39.81
EV/EBITDA 45.22
EPS(TTM)5.2
EY2.27%
EPS(NY)5.91
Fwd EY2.58%
FCF(TTM)5.71
FCFY2.49%
OCF(TTM)6.38
OCFY2.79%
SpS36.65
BVpS26.27
TBVpS5.75
PEG (NY)4.37
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 10.3%
ROE 20.04%
ROCE 11.95%
ROIC 8.78%
ROICexc 18.16%
ROICexgc N/A
OM 10.56%
PM (TTM) 14.36%
GM 75.67%
FCFM 15.58%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.92
Debt/EBITDA 1.09
Cap/Depr 71.02%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 132.6%
Profit Quality 108.49%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z 7.46
F-Score7
WACC8%
ROIC/WACC1.1
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)40.62%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%22.96%
EPS Next Y10.08%
EPS Next 2Y11.31%
EPS Next 3Y11.26%
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%31.95%
Revenue Next Year10.68%
Revenue Next 2Y11.19%
Revenue Next 3Y11.57%
Revenue Next 5YN/A
EBIT growth 1Y-0.02%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year2.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y10%
OCF growth 3Y9.02%
OCF growth 5Y29.8%